Structural Biology in Cancer Research

Structural Biology in Cancer Research

The major part of research is being carried out in the area of cancer. The main aim is to design and discover novel and effective drugs to cure the disease. Structural biology combined with molecular modeling mainly aims at drug designing. Eventually, many researchers in Structural biology carry out cancer research to extend the exploitation of molecular understanding of biomolecules in the advancement of novel cancer therapies. Cancer immunotherapy is also used which is defined as the response of immune system to reject cancer. Immunotherapies can be a better way of treating cancer. The malignant tumor cells are attacked by stimulating the immune system as these cells are responsible to exploit the fact that cancer cells often have molecules on their surface that can be detected by the tumor-associated antigens (TAAs).

  • Antibody Therapy

  • Cellular Immunotherapy

  • Cytokine Therapy

  • Combinational Immunotherapy

    Related Conference of Structural Biology in Cancer Research

    April 17-18, 2023

    13th World Glycobiology Congress

    Rome, Italy
    June 19-20, 2023

    5th International Conference on Biochemistry

    London, UK
    June 19-20, 2023

    5th International Conference on Nucleic Acids

    London, UK
    September 21-22, 2023

    19th World Congress on Structural Biology

    Paris, France
    September 21-22, 2023

    14th International Conference on Biofuels and Bioenergy

    Toronto, Canada
    October 30-31, 2023

    14th World Congress on Cell & Tissue Science

    Rome, Italy
    November 01-02, 2023

    19th International Conference on Metabolomics

    Rome, Italy

    Structural Biology in Cancer Research Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in